Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
General Internal Medicine
•
Neurology
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
Related Questions
When do you attribute tremors to lamotrigine?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
What prompts you to procure EEG and/or imaging in patients presenting with multiple simple febrile seizures?
When do you use seizure prophylaxis in patients on clozapine?
How do you approach using antipsychotic medication in patients with epilepsy?
What is the optimal antithrombotic management, if at all, in patients with incidentally identified findings of multiple silent embolic appearing cerebral infarcts?
How do you transition from Levetiracetam to Brivaracetam, particularly at doses of 1500 mg BID or higher?
When do you use wearable EEG or epilepsy detection devices for epilepsy management?
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
How do you manage stroke-related abulia?
